Latest period
$82.75B
YoY change
+19.0%
5Y CAGR
+4.9%
Peak year (2025)
$84.20B
Latest annual
$84.20B
Total Liabilities history chart for Merck & Co. (MRK) from 1985 to 2025
Latest: $84.20B
Total Liabilities growth chart for Merck & Co. (MRK) from 1985 to 2025
Latest: +19.0%
Total Liabilities history table for Merck & Co. (MRK) from 1985 to 2025
| 2025 | $84.20B | +19.0% | +$13.47B | ||
| 2024 | $70.73B | +2.5% | +$1.69B | ||
| 2023 | $69.04B | +9.4% | +$5.94B | ||
| 2022 | $63.10B | -6.4% | −$4.33B | ||
| 2021 | $67.44B | +1.9% | +$1.25B | ||
| 2020 | $66.18B | +13.3% | +$7.79B | ||
| 2019 | $58.40B | +4.7% | +$2.64B | ||
| 2018 | $55.76B | +4.6% | +$2.45B | ||
| 2017 | $53.30B | -3.2% | −$1.77B | ||
| 2016 | $55.07B | -3.2% | −$1.84B | ||
| 2015 | $56.91B | +15.3% | +$7.53B | ||
| 2014 | $49.38B | -7.4% | −$3.94B | ||
| 2013 | $53.32B | +5.2% | +$2.65B | ||
| 2012 | $50.67B | +5.2% | +$2.48B | ||
| 2011 | $48.19B | -1.6% | −$791.00M | ||
| 2010 | $48.98B | -3.6% | −$1.85B | ||
| 2009 | $50.83B | +95.3% | +$24.80B | ||
| 2008 | $26.03B | -6.2% | −$1.73B | ||
| 2007 | $27.76B | +12.8% | +$3.16B | ||
| 2006 | $24.60B | +0.6% | +$143.10M | ||
| 2005 | $24.46B | +6.9% | +$1.58B | ||
| 2004 | $22.88B | +8.4% | +$1.78B | ||
| 2003 | $21.10B | -13.7% | −$3.34B | ||
| 2002 | $24.43B | +5.6% | +$1.30B | ||
| 2001 | $23.13B | +15.3% | +$3.08B | ||
| 2000 | $20.06B | +5.9% | +$1.12B | ||
| 1999 | $18.93B | +23.4% | +$3.59B | ||
| 1998 | $15.35B | +28.2% | +$3.37B | ||
| 1997 | $11.98B | +19.6% | +$1.96B | ||
| 1996 | $10.01B | +2.1% | +$202.60M | ||
| 1995 | $9.81B | +3.2% | +$301.00M | ||
| 1994 | $9.51B | +8.5% | +$747.40M | ||
| 1993 | $8.76B | +60.6% | +$3.31B | ||
| 1992 | $5.46B | +36.8% | +$1.47B | ||
| 1991 | $3.99B | +9.4% | +$341.60M | ||
| 1990 | $3.65B | +33.7% | +$919.90M | ||
| 1989 | $2.73B | -16.7% | −$545.50M | ||
| 1988 | $3.27B | -8.2% | −$291.60M | ||
| 1987 | $3.56B | +40.5% | +$1.03B | ||
| 1986 | $2.54B | +11.8% | +$267.90M | ||
| 1985 | $2.27B | — | — |
- 2025$84.20B+19.0%
- 2024$70.73B+2.5%
- 2023$69.04B+9.4%
- 2022$63.10B-6.4%
- 2021$67.44B+1.9%
- 2020$66.18B+13.3%
- 2019$58.40B+4.7%
- 2018$55.76B+4.6%
- 2017$53.30B-3.2%
- 2016$55.07B-3.2%
- 2015$56.91B+15.3%
- 2014$49.38B-7.4%
- 2013$53.32B+5.2%
- 2012$50.67B+5.2%
- 2011$48.19B-1.6%
- 2010$48.98B-3.6%
- 2009$50.83B+95.3%
- 2008$26.03B-6.2%
- 2007$27.76B+12.8%
- 2006$24.60B+0.6%
- 2005$24.46B+6.9%
- 2004$22.88B+8.4%
- 2003$21.10B-13.7%
- 2002$24.43B+5.6%
- 2001$23.13B+15.3%
- 2000$20.06B+5.9%
- 1999$18.93B+23.4%
- 1998$15.35B+28.2%
- 1997$11.98B+19.6%
- 1996$10.01B+2.1%
- 1995$9.81B+3.2%
- 1994$9.51B+8.5%
- 1993$8.76B+60.6%
- 1992$5.46B+36.8%
- 1991$3.99B+9.4%
- 1990$3.65B+33.7%
- 1989$2.73B-16.7%
- 1988$3.27B-8.2%
- 1987$3.56B+40.5%
- 1986$2.54B+11.8%
- 1985$2.27B—
Total Liabilities values are taken from Merck & Co.'s reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's latest reported total liabilities is $82.75B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Merck & Co. (MRK) reported total liabilities of $84.20B – grew 19.0% year-over-year.
Through 2020–2025 (5 years), Merck & Co. total liabilities delivered a +4.9% annualised rate; with mixed annual results across the window.
The record annual total liabilities stands at $84.20B, reached in 2025; the historical low of $2.27B was recorded in 1985.
Merck & Co. Total Liabilities by Year
Merck & Co. Total Liabilities 2025: $84.20B
In 2025, Merck & Co. reported total liabilities of $84.20B, grew 19.0% from 2024. This figure represents the highest annual value in the available history.
Merck & Co. Total Liabilities 2024: $70.73B
Merck & Co. total liabilities in 2024 was $70.73B, edged up 2.5% from 2023.
Merck & Co. Total Liabilities 2023: $69.04B
2023's total liabilities for Merck & Co. came in at $69.04B, grew 9.4% from 2022.
Merck & Co. Total Liabilities 2022: $63.10B
Merck & Co. posted total liabilities of $63.10B in 2022, declined 6.4% below 2021.
Merck & Co. Total Liabilities 2021: $67.44B
Merck & Co. total liabilities in 2021 was $67.44B.
See more financial history for Merck & Co. (MRK).
Sector peers by Total Liabilities
Healthcare peers of Merck & Co. (MRK), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $81.93B | |
| $65.36B | |
| $56.81B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation